Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters

Journal of Agricultural and Food Chemistry

Volumn 53, Issue 16, 2005, Pages 6289-6293

  Chi, Ho Ng ^a   Ka, Yiu Leung ^a   Huang, Yu ^a   Zhen, Yu Chen ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cholesterol; HDL; LDL; Octacosanol; Policosanol; Primary alcohol; Triacontanol; Triglyceride

Indexed keywords

ANTIOXIDANT; BILE ACID; CHOLESTEROL; FATTY ALCOHOL; LIPID; LOW DENSITY LIPOPROTEIN; POLICOSANOL;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DIET; DRUG EFFECT; FECES; HAMSTER; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; SYRIAN HAMSTER;

ANIMALS; ANTIOXIDANTS; BILE ACIDS AND SALTS; CHOLESTEROL; CRICETINAE; DIET; FATTY ALCOHOLS; FECES; HUMANS; LIPID PEROXIDATION; LIPIDS; LIPOPROTEINS, LDL; MALE; MESOCRICETUS;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 23844479225     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf051269a     Document Type: Article

References (23)

1. Castano, G.; Menendez, R.; Mas, R.; Amor, A.; Fernandez, J. L.; Gonsalez, R.; Lezcay, M.; Alvarez, E. Effects of policaosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus. Int. J. Clin. Phasmacol. Res. 2002, 22, 89-99.
2. Castano, G.; Mas, R.; Fernandez, L.; Fernandez, J. C.; Illnait, J.; Lopez, L. E.; Alvarez, E. Effects of policosanol on post-menopausal women with type II hypercholesterolemia. Gynecol. Endocrinol. 2000, 14, 187-195.
3. Pons, P.; Mas, R.; Illnait, J. Efficacy and safety of policosanol in patients with primary hypercholesterolaemia. Curr. Ther. Res. 1992, 52, 507-513.
4. Menendez, R.; Arruzazabala, L.; Mas, R.; del Rio, A.; Amor, A. M.; Gonzalez, R. M.; Carbajal, D.; Fraga, V.; Molina, V.; Illnait, J. Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolemia induced by a wheat starch-casein diet. Br. J. Nutr. 1997, 77, 923-932.
5. Rodriguez-Echenique, C.; Mesa, R.; Mas, R.; Noa, M.; Menendez, R.; Gonzalez, R. M.; Amor, A. M.; Fraga, V.; Sotolongo, V.; Laguna, A. Effects of policosanol chronically administered in male monkeys (Macaca arctoides). Food. Chem. Toxicol. 1994, 32, 565-575.
6. Mesa, A. R.; Mas, R.; Noa, M.; Hernandez, C.; Rodeiro, I.; Gamez, R.; Garcia, M.; Capote, A.; Aleman, C. L. Toxicity of policosanol in beagle dogs: One-year study. Toxicol. Lett. 1994, 73, 81-90.
7. Noa, M.; Mas, R.; de la Rosa, M. C.; Graner, J. Effect of policosanol on lipofundin-induced atherosclerotic lesions in rats. J. Pharm. Pharmacol. 1995, 47, 289-291.
8. Lin, Y.; Rudrum, M.; van der Wielen, R. P. J.; Trautwein, E. A.; McNeill, G.; Sierksma, A.; Meijer, G. W. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentration. Metabolism 2004, 53, 1309-1314.
9. Wang, Y. W.; Jones, P. J.; Pischel, I.; Fairow, C. Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters. Lipids 2003, 38, 165-70.
10. McCarty, M. F. Policosanol safely dow-regulates HMG-CoA reductase-potential as a component of the Esselstyn regimen. Med. Hypotheses 2002, 59, 268-279.
11. Menendez, R.; Amor, A. M.; Rodeiro, I.; Gonzalez, R. M.; Gonzalez, P. C.; Alfonso, J. L.; Mas, R. Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts. Arch. Med. Res. 2001, 32, 8-12.
12. Menendez, R.; Fernandez, S. I.; del Rio, A.; Gonzalez, R. M.; Fraga, V.; Amor, A. M.; Mas, R. M. Policosanol inhibits cholesterol biosynthesis and enhances low-density lipoprotein processing in cultured human fibroblasts. Biol. Res. 1994, 27, 199-203.
13. Menendez, R.; Fraga, V.; Amor, A. M.; Gonzalez, R. M.; Mas, R. Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation. Physiol Behav. 1999, 67, 1-7.
14. Carbajal, D.; Arruzazabala, M. L.; Valdes, S.; Mas, R. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers. Prostaglandins, Leukotrienes Essent. Fatty Acids 1998, 58, 61-64.
15. Arruzazabala, M. L.; Molina, V.; Carbajal, D.; Valdes, S.; Mas, R. Effect of Policosanol on cerebral ischemia in Mongolian gerbils: Role of prostacyclin and thromboxane A2. Prostaglandins, Leukotrienes Essent. Fatty Acids 1993, 49, 695-697.
16. Zhang, Z.; Yeung, W. K.; Huang, Y.; Chen, Z. Y. Hyperlipidemic activity of dietary squalene and shark liver oil in hamsters. Int. J. Food Sci. Nutr. 2002, 53, 411-418.
17. Chan, P. T.; Fong, W. P.; Cheung, Y. L.; Huang, Y.; Ho, W. K. K.; Chen, Z. Y. Jasmine green epicatechins are hypolipidemic in hamsters fed a high fat diet. J. Nutr. 1999, 129, 1094-1101.
18. Zhang, A.; Chan, P. T.; Luk, Y. S.; Ho, W. K. K.; Chen, Z. Y. inhibitory effect of jasmine green tea epicatechin isomers on LDL-oxidation. J. Nutr. Biochem. 1997, 8, 334-340.
19. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
20. Blois, M. S. Antioxidant determination by the use of stable free radical. Nature 1958, 181, 1199-1200.
21. Arruzazabala, M. L.; Molina, V.; Mas, R.; Fernandez, L.; Carbajal, D.; Valdes, S.; Castano, G. Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and duslipidaemic patients. Clin. Exp. Pharmacol. Physiol. 2002, 29, 891-897.
22. Menendez, R.; Mas, R.; Amor, A. M. A.; Gonzalez, R. M. A.; Fernandez, J. C.; Rodeiro, I.; Zayas, M.; Jimenez, S. Effects of policosanol treatment on the susceptibility of low-density lipoprotein (LDL) isolated from healthy volunteers to oxidatie modification in vitro. Br. J. Clin. Pharmacol. 2000, 50, 255-262.
23. Mas, R.; Castano, G.; Fernandez, J.; Gamez, R.; Illnait, J.; Fernandez, L.; Lopez, E.; Mesa, M.; Alvarez, E.; Mendoza, S. Long-term effects of policosanol on obese patients with Type II Hypercholesterolemia. Asia. Pac. J. Clin. Nutr. 2004, 13, S102.